Clinical outcome after surgical aortic valve replacement in low-risk Japanese patients with severe aortic stenosis.
Aortic stenosis
Surgical aortic valve replacement
Journal
Cardiovascular intervention and therapeutics
ISSN: 1868-4297
Titre abrégé: Cardiovasc Interv Ther
Pays: Japan
ID NLM: 101522043
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
23
12
2019
accepted:
27
02
2020
pubmed:
15
3
2020
medline:
18
5
2021
entrez:
15
3
2020
Statut:
ppublish
Résumé
Two randomized control trials demonstrated that transcatheter aortic valve implantation was associated with 1-2 year clinical outcomes comparable or even superior to surgical aortic valve replacement (SAVR) in low surgical risk patients with severe aortic stenosis (AS). However, no previous study has reported the clinical outcomes after SAVR in Japanese patients with low surgical risk. From 3815 consecutive patients enrolled in the CURRENT AS registry, we retrieved 220 patients who underwent SAVR in reference to the inclusion and exclusion criteria of the PARTNER 3 trial. Age and surgical risk score in the current study population were comparable to those in the PARTNER 3 trial (Age: 75 years versus 74 years, and STS-PROM score: 2.3 versus 1.9). The cumulative incidence of a composite all-cause death or stroke was comparable between the current study population and the SAVR patients in the PARTNER 3 trial both at 30-day (2.3% versus 3.3%), and at 1-year (4.1% versus 4.9%). The clinical outcomes of SAVR in low surgical risk patients with severe AS selected from a real world Japanese registry according to the inclusion and exclusion criteria of the PARTNER 3 trial was favorable and numerically comparable to those of SAVR patients in the PARTNER 3 trial.
Identifiants
pubmed: 32170553
doi: 10.1007/s12928-020-00658-2
pii: 10.1007/s12928-020-00658-2
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
121-130Références
Braunwald E. Aortic stenosis: then and now. Circulation. 2018;137:2099–100. https://doi.org/10.1161/circulationaha.118.033408 .
doi: 10.1161/circulationaha.118.033408
pubmed: 29650546
Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation. 1981;64:184–8.
Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–10.
doi: 10.1161/01.CIR.66.5.1105
Brennan JM, Edwards FH, Zhao Y, O'Brien SM, Douglas PS, Peterson ED. Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007. Circulation. 2012;126:1621–9. https://doi.org/10.1161/circulationaha.112.091371 .
doi: 10.1161/circulationaha.112.091371
pubmed: 22907936
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57–185. https://doi.org/10.1016/j.jacc.2014.02.536 .
doi: 10.1016/j.jacc.2014.02.536
pubmed: 24603191
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91. https://doi.org/10.1093/eurheartj/ehx391 .
doi: 10.1093/eurheartj/ehx391
pubmed: 28886619
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–89. https://doi.org/10.1016/j.jacc.2017.03.011 .
doi: 10.1016/j.jacc.2017.03.011
pubmed: 28315732
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607. https://doi.org/10.1056/NEJMoa1008232 .
doi: 10.1056/NEJMoa1008232
pubmed: 20961243
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. https://doi.org/10.1056/NEJMoa1103510 .
doi: 10.1056/NEJMoa1103510
pubmed: 21639811
Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95. https://doi.org/10.1056/NEJMoa1200384 .
doi: 10.1056/NEJMoa1200384
pubmed: 22443479
Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704. https://doi.org/10.1056/NEJMoa1202277 .
doi: 10.1056/NEJMoa1202277
pubmed: 22443478
Kapadia SR, Tuzcu EM, Makkar RR, Svensson LG, Agarwal S, Kodali S, et al. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation. 2014;130:1483–92. https://doi.org/10.1161/circulationaha.114.009834 .
doi: 10.1161/circulationaha.114.009834
pubmed: 25205802
Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2485–91. https://doi.org/10.1016/s0140-6736(15)60290-2 .
doi: 10.1016/s0140-6736(15)60290-2
pubmed: 25788231
Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84. https://doi.org/10.1016/s0140-6736(15)60308-7 .
doi: 10.1016/s0140-6736(15)60308-7
pubmed: 25788234
Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20. https://doi.org/10.1056/NEJMoa1514616 .
doi: 10.1056/NEJMoa1514616
pubmed: 27040324
Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25. https://doi.org/10.1016/s0140-6736(16)30073-3 .
doi: 10.1016/s0140-6736(16)30073-3
pubmed: 27053442
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–705. https://doi.org/10.1056/NEJMoa1814052 .
doi: 10.1056/NEJMoa1814052
pubmed: 30883058
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706–15. https://doi.org/10.1056/NEJMoa1816885 .
doi: 10.1056/NEJMoa1816885
pubmed: 30883053
Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66:2827–38. https://doi.org/10.1016/j.jacc.2015.10.001 .
doi: 10.1016/j.jacc.2015.10.001
pubmed: 26477634
Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42:S45–60. https://doi.org/10.1093/ejcts/ezs533 .
doi: 10.1093/ejcts/ezs533
pubmed: 23026738
Rao V, Jamieson WR, Ivanov J, Armstrong S, David TE. Prosthesis-patient mismatch affects survival after aortic valve replacement. Circulation. 2000;102:5–9. https://doi.org/10.1161/01.cir.102.suppl_3.iii-5 .
doi: 10.1161/01.cir.102.suppl_3.iii-5
Handa N, Kumamaru H, Torikai K, Kohsaka S, Takayama M, Kobayashi J, et al. Learning curve for transcatheter aortic valve implantation under a controlled introduction system-initial analysis of a Japanese Nationwide Registry. Circ J. 2018;82:1951–8. https://doi.org/10.1253/circj.CJ-18-0211 .
doi: 10.1253/circj.CJ-18-0211
pubmed: 29794375